The “Iron”-y of Iron Overload and Iron Deficiency in Chronic Obstructive Pulmonary Disease
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Chronic obstructive pulmonary disease (COPD) is a debilitating inflammatory lung disease associated with cigarette smoking and is third leading cause of death worldwide. With the recent emergence of genome wide association studies (GWAS), the identification of multiple COPD susceptibility genes has enhanced and expanded our understanding of the pathogenic mechanisms associated with this debilitating lung disease. An example of such a pathogenic mechanism is the role of iron metabolism in the onset and progression of COPD. Historic observations of iron dysregulation in COPD can now be enlightened by the recent revelations that genetic polymorphisms in the gene iron regulatory protein-2 (IRP-2) associate with COPD susceptibility. A functional role for IRP-2 is supported by IRP-2 overexpression in murine models, that demonstrates cellular and mitochondrial iron accumulation in the lung linked with manifestations of experimental COPD. Increased IRP2 may explain the excessive iron deposition in alveolar macrophages and tissue in smokers and in patients with COPD. Changes in IRP2 expression may also associate with systemic iron mismanagement, which may explain the prevalence of systemic iron deficiency and iron-deficiency anemia in patients with COPD. It may also help to explain why patients with COPD and/or iron deficiency manifest altered responses to hypoxia including erythropoiesis and pulmonary hypertension. We provide a concise review of the role of iron in the pathogenesis, susceptibility and progression of COPD and highlight the prospective therapeutic interventions for treating both local and systemic iron dysregulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · cited 2×
“IL-6 is important in the pathogenesis of COPD and is known to regulate iron homeostasis through induction of hepcidin expression (42).”
BackgroundA variant associated with nicotine dependence, lung cancer and peripheral arterial disease
Thorgeirsson, T. E., Geller, F., Sulem, P., Rafnar, T., Wiste, A., Magnusson, K. P., Manolescu, A., Thorleifsson, G., Stefansson, H., Ingason, A., et al. (2008) · Nature · doi:10.1038/nature06846 · Cited by 1,523
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026 · cited 1×
“Hepcidin expression and release are induced by increased serum iron, by bone morphogenetic protein signaling (41), and by a number of proinflammatory cytokines, including IL-6 and IL-22 (42).”
BackgroundIron homeostasis in host defence and inflammation
Ganz, T., & Nemeth, E. (2015) · Nature Reviews Immunology · doi:10.1038/nri3863 · Cited by 843 · cited 4×
“Upregulation of hepcidin expression results in ferroportin endocytosis and proteolysis, preventing cellular iron export and reducing the influx of iron into the plasma from stores, as well as blocking further absorption of dietary iron (14).”
BackgroundInfluentialMitophagy-dependent necroptosis contributes to the pathogenesis of COPD
Mizumura, K., Cloonan, S. M., Nakahira, K., Bhashyam, A. R., Cervo, M., Kitada, T., Glass, K., Owen, C. A., Mahmood, A., Washko, G. R., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74985 · Cited by 611
Self-citationSaccone, N. L., Culverhouse, R. C., Schwantes-An, T.-H., Cannon, D. S., Chen, X., Cichon, S., Giegling, I., Han, S., Han, Y., Keskitalo-Vuokko, K., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001053 · Cited by 395
Smith, J. R., & Landaw, S. A. (1978) · New England Journal of Medicine · doi:10.1056/nejm197801052980102 · Cited by 249
Huang, M. L.-H., Becker, E. M., Whitnall, M., Rahmanto, Y. S., Ponka, P., & Richardson, D. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906784106 · Cited by 212
Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications
Sohn, Y.-S., Breuer, W., Munnich, A., & Cabantchik, Z. I. (2008) · Blood · doi:10.1182/blood-2007-07-102335 · Cited by 167 · cited 1×
“Intracellular iron chelators such as deferiprone, which specifically target intracellular iron deposits and relocate them outside the cell to prevent cellular iron loading (112, 113), may have more therapeutic efficacy than regular cell-impermeable iron chelators such as deferoxamine (114).”
BackgroundIron metabolism in the lower respiratory tract
Mateos, F., Brock, J. H., & Perez-Arellano, J. L. (1998) · Thorax · doi:10.1136/thx.53.7.594 · Cited by 158
Iron levels in polarized macrophages: regulation of immunity and autoimmunity
Recalcati, S., Locati, M., Gammella, E., Invernizzi, P., & Cairo, G. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.03.003 · Cited by 150 · cited 1×
“Iron-regulatory responses differ between these phenotypes: M1 cells accumulate iron as part of a bacteriostatic stratagem linked to the anemia of chronic inflammation, whereas the opposite is the case for M2 cells, where iron release is favored (48).”
BackgroundHepcidin expression and iron transport in alveolar macrophages
Nguyen, N.-B., Callaghan, K. D., Ghio, A. J., Haile, D. J., & Yang, F. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00484.2005 · Cited by 143 · cited 1×
“Production of hepcidin by AMs has also been described (43), indicating a specific local role in the lung for this hormone.”
BackgroundDesign of iron chelators with therapeutic application
Zhou, T., Ma, Y., Kong, X., & Hider, R. C. (2012) · Dalton Transactions · doi:10.1039/c2dt12159j · Cited by 136 · cited 1×
“Intracellular iron chelators such as deferiprone, which specifically target intracellular iron deposits and relocate them outside the cell to prevent cellular iron loading (112, 113), may have more therapeutic efficacy than regular cell-impermeable iron chelators such as deferoxamine (114).”
BackgroundCigarette smoke extract affects mitochondrial function in alveolar epithelial cells
Ballweg, K., Mutze, K., Königshoff, M., Eickelberg, O., & Meiners, S. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00180.2014 · Cited by 128 · cited 1×
“CS induces mitophagy in vitro (12, 13), and loss of mitophagy is protective in murine models of COPD (110), suggesting that increased mitophagy, though it is a protective strategy, may ultimately be detrimental in the context of COPD.”
BackgroundGhio, A. J., Carter, J. D., Richards, J. H., Richer, L. D., Grissom, C. K., & Elstad, M. R. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050284.35609.97 · Cited by 105 · cited 3×
“Furthermore, total nonheme iron and ferritin levels are increased in BAL fluid and in AMs of smokers compared with nonsmokers (49, 51–58), and redox-active iron levels in resistance-associated macrophage protein 1 (NRAMP1, also known as SLC11A1).”
BackgroundHardin, M., Zielinski, J., Wan, E. S., Hersh, C. P., Castaldi, P. J., Schwinder, E., Hawrylkiewicz, I., Sliwinski, P., Cho, M. H., & Silverman, E. K. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0011oc · Cited by 104 · cited 1×
“This association may be sex specific (8, 71) and independent of smoking (72, 73), and it may also associate with severe alpha-1 antitrypsin (AAT) deficiency (71) and lung cancer (74, 75).”
BackgroundMitochondrial Mayhem: The Mitochondrion as a Modulator of Iron Metabolism and Its Role in Disease
Huang, M. L.-H., Lane, D. J. R., & Richardson, D. R. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3921 · Cited by 103 · cited 1×
“Iron accumulation enhances the production of reactive oxygen species and induces mitochondrial dysfunction (97, 98), both of which are extensively documented in patients with COPD and model systems (49, 51, 57, 99–103).”
BackgroundHepcidin and iron disorders: new biology and clinical approaches
Arezes, J., & Nemeth, E. (2015) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12358 · Cited by 88 · cited 4×
“In macrophages and EPIs, ferroportin function is regulated by hepcidin (encoded by HAMP), a hormone produced chiefly in the liver, which regulates, and is in turn regulated by, systemic iron levels (40) (Figure 2).”
BackgroundInfluentialLEIFERT, J. A. (2008) · International Journal of Laboratory Hematology · doi:10.1111/j.1751-553x.2008.01067.x · Cited by 83
Seifert, M., Nairz, M., Schroll, A., Schrettl, M., Haas, H., & Weiss, G. (2008) · Immunobiology · doi:10.1016/j.imbio.2008.07.010 · Cited by 51
Apical location of ferroportin 1 in airway epithelia and its role in iron detoxification in the lung
Yang, F., Haile, D. J., Wang, X., Dailey, L. A., Stonehuerner, J. G., & Ghio, A. J. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00456.2004 · Cited by 47 · cited 1×
“Ferroportin-mediated iron release occurs at the apical membrane of ECs and plays an important role in iron detoxification (39).”
BackgroundWood Smoke Particle Sequesters Cell Iron to Impact a Biological Effect
Ghio, A. J., Soukup, J. M., Dailey, L. A., Tong, H., Kesic, M. J., Budinger, G. R. S., & Mutlu, G. M. (2015) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00270 · Cited by 41
Boutou, A. K., Pitsiou, G. G., Stanopoulos, I., Kontakiotis, T., Kyriazis, G., & Argyropoulou, P. (2012) · QJM · doi:10.1093/qjmed/hcs024 · Cited by 37
Research works printed but not linked: 103
- Burney, 2015, Global and regional trends in COPD mortality, 1990–2010, Eur Respir J, 45, 1239, 10.1183/09031936.00142414 · DOI · Paper page
- Mannino, 2007, Global burden of COPD: risk factors, prevalence, and future trends, Lancet, 370, 765, 10.1016/S0140-6736(07)61380-4 · DOI · Paper page
- Decramer, 2012, Chronic obstructive pulmonary disease, Lancet, 379, 1341, 10.1016/S0140-6736(11)60968-9 · DOI · Paper page
- Mortimer, 2012, Household air pollution is a major avoidable risk factor for cardiorespiratory disease, Chest, 142, 1308, 10.1378/chest.12-1596 · DOI
- DeMeo, 2009, Integration of genomic and genetic approaches implicates IREB2 as a COPD susceptibility gene, Am J Hum Genet, 85, 493, 10.1016/j.ajhg.2009.09.004 · DOI · Paper page
- Chappell, 2011, The role of IREB2 and transforming growth factor β-1 genetic variants in COPD: a replication case-control study, BMC Med Genet, 12, 24, 10.1186/1471-2350-12-24 · DOI · Paper page
- Du, 2016, Association of IREB2 gene rs2568494 polymorphism with risk of chronic obstructive pulmonary disease: a meta-analysis, Med Sci Monit, 22, 177, 10.12659/MSM.894524 · DOI
- Ding, 2014, Association of genetic polymorphisms with chronic obstructive pulmonary disease in the Hainan population: a case-control study, Int J Chron Obstruct Pulmon Dis, 10, 7, 10.2147/COPD.S73042 · DOI
- Ghio, 2009, Disruption of iron homeostasis and lung disease, Biochim Biophys Acta, 1790, 731, 10.1016/j.bbagen.2008.11.004 · DOI
- Kurz, 2011, Cell sensitivity to oxidative stress is influenced by ferritin autophagy, Free Radic Biol Med, 50, 1647, 10.1016/j.freeradbiomed.2011.03.014 · DOI
- Ito, 2015, PARK2-mediated mitophagy is involved in regulation of HBEC senescence in COPD pathogenesis, Autophagy, 11, 547, 10.1080/15548627.2015.1017190 · DOI · Paper page
- John, 2006, Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases, Int J Cardiol, 111, 365, 10.1016/j.ijcard.2005.07.043 · DOI
- Martinez-Rivera, 2012, Anemia is a mortality predictor in hospitalized patients for COPD exacerbation, COPD, 9, 243, 10.3109/15412555.2011.647131 · DOI
- Boutou, 2013, Anemia and survival in chronic obstructive pulmonary disease: a dichotomous rather than a continuous predictor, Respiration, 85, 126, 10.1159/000338792 · DOI
- Nickol, 2015, A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease, BMJ Open, 5, e007911, 10.1136/bmjopen-2015-007911 · DOI · Paper page
- Mackay, 2015, Serum amyloid A and hepcidin elevations characterise bacterial-associated exacerbations in frequently exacerbating COPD patients [abstract], Am J Respir Crit Care Med, 191, A6336
- Takemoto, 1991, Metal concentrations in human lung tissue, with special reference to age, sex, cause of death, emphysema and contamination of lung tissue, Int Arch Occup Environ Health, 62, 579, 10.1007/BF00381111 · DOI
- Díez, 1989, Serum and tissue trace metal levels in lung cancer, Oncology, 46, 230, 10.1159/000226722 · DOI · Paper page
- Sirlin, 2010, Magnetic resonance imaging quantification of liver iron, Magn Reson Imaging Clin N Am, 18, 359, 10.1016/j.mric.2010.08.014 · DOI · Paper page
- Van Eijk, 1974, Measurement of the iron content in human liver specimens, Clin Chim Acta, 50, 275, 10.1016/0009-8981(74)90375-1 · DOI
- Carpenter, 2011, On T2* magnetic resonance and cardiac iron, Circulation, 123, 1519, 10.1161/CIRCULATIONAHA.110.007641 · DOI · Paper page
- World Health Organization (WHO)., 1996, Guidelines for drinking-water quality
- Kim, 2011, Influence of DMT1 and iron status on inflammatory responses in the lung, Am J Physiol Lung Cell Mol Physiol, 300, L659, 10.1152/ajplung.00343.2010 · DOI
- Du, 2015, ‘LungGENS’: a web-based tool for mapping single-cell gene expression in the developing lung, Thorax, 70, 1092, 10.1136/thoraxjnl-2015-207035 · DOI · Paper page
- Lindskog, 2014, The lung-specific proteome defined by integration of transcriptomics and antibody-based profiling, FASEB J, 28, 5184, 10.1096/fj.14-254862 · DOI · Paper page
- Heilig, 2006, Manganese and iron transport across pulmonary epithelium, Am J Physiol Lung Cell Mol Physiol, 290, L1247, 10.1152/ajplung.00450.2005 · DOI · Paper page
- Wu, 2011, Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD, Respir Med, 105, 329, 10.1016/j.rmed.2010.11.001 · DOI
- Cloonan, 2016, Mitochondrial iron chelation ameliorates cigarette smoke-induced bronchitis and emphysema in mice, Nat Med, 22, 163, 10.1038/nm.4021 · DOI · Paper page
- Szabó, 1980, Local production of proteins in normal human bronchial secretion, Respiration, 39, 172, 10.1159/000194213 · DOI
- Fracchia, 1999, A comparative study on ferritin concentration in serum and bilateral bronchoalveolar lavage fluid of patients with peripheral lung cancer versus control subjects, Oncology, 56, 181, 10.1159/000011962 · DOI
- Ghio, 1999, Respiratory epithelial cells demonstrate lactoferrin receptors that increase after metal exposure, Am J Physiol, 276, L933
- Kono, 2010, Biological effects of mutant ceruloplasmin on hepcidin-mediated internalization of ferroportin, Biochim Biophys Acta, 1802, 968, 10.1016/j.bbadis.2010.07.011 · DOI
- Iwamoto, 2014, Differences in plasma and sputum biomarkers between COPD and COPD–asthma overlap, Eur Respir J, 43, 421, 10.1183/09031936.00024313 · DOI
- Carraway, 1998, Induction of ferritin and heme oxygenase-1 by endotoxin in the lung, Am J Physiol, 275, L583
- Damron, 2016, Dual-seq transcriptomics reveals the battle for iron during Pseudomonas aeruginosa acute murine pneumonia, Sci Rep, 6, 39172, 10.1038/srep39172 · DOI · Paper page
- Galván-Peña, 2014, Metabolic reprograming in macrophage polarization, Front Immunol, 5, 420
- Thompson, 1991, Lower respiratory tract iron burden is increased in association with cigarette smoking, J Lab Clin Med, 117, 493
- Mussalo-Rauhamaa, 1986, Cigarettes as a source of some trace and heavy metals and pesticides in man, Arch Environ Health, 41, 49, 10.1080/00039896.1986.9935765 · DOI · Paper page
- Ghio, 2008, Particulate matter in cigarette smoke alters iron homeostasis to produce a biological effect, Am J Respir Crit Care Med, 178, 1130, 10.1164/rccm.200802-334OC · DOI · Paper page
- Corhay, 1992, Iron content in human alveolar macrophages, Eur Respir J, 5, 804, 10.1183/09031936.93.05070804 · DOI · Paper page
- McGowan, 1988, Iron and ferritin contents and distribution in human alveolar macrophages, J Lab Clin Med, 111, 611
- Philippot, 2014, Increased iron sequestration in alveolar macrophages in chronic obstructive pulmonary disease, PLoS One, 9, e96285, 10.1371/journal.pone.0096285 · DOI · Paper page
- Wesselius, 1992, Alveolar macrophage content of isoferritins and transferrin: comparison of nonsmokers and smokers with and without chronic airflow obstruction, Am Rev Respir Dis, 145, 311, 10.1164/ajrccm/145.2_Pt_1.311 · DOI · Paper page
- Wesselius, 1994, Increased release of ferritin and iron by iron-loaded alveolar macrophages in cigarette smokers, Am J Respir Crit Care Med, 150, 690, 10.1164/ajrccm.150.3.8087339 · DOI · Paper page
- Nelson, 1996, Regional variation in iron and iron-binding proteins within the lungs of smokers, Am J Respir Crit Care Med, 153, 1353, 10.1164/ajrccm.153.4.8616566 · DOI · Paper page
- Mumby, 2016, Decreased breath excretion of redox active iron in COPD: a protective failure?, Eur Respir J, 47, 1267, 10.1183/13993003.01710-2015 · DOI · Paper page
- Lee, 2016, Association of serum ferritin levels with smoking and lung function in the Korean adult population: analysis of the fourth and fifth Korean National Health and Nutrition Examination Survey, Int J Chron Obstruct Pulmon Dis, 11, 3001, 10.2147/COPD.S116982 · DOI
- Shibata, 2013, Elevated serum iron is a potent biomarker for spirometric resistance to cigarette smoke among Japanese males: the Takahata study, PLoS One, 8, e74020, 10.1371/journal.pone.0074020 · DOI
- McKeever, 2008, A multivariate analysis of serum nutrient levels and lung function, Respir Res, 9, 67, 10.1186/1465-9921-9-67 · DOI · Paper page
- Nordenberg, 1990, The effect of cigarette smoking on hemoglobin levels and anemia screening, JAMA, 264, 1556, 10.1001/jama.1990.03450120068031 · DOI · Paper page
- Sadreameli, 2016, Secondhand smoke is an important modifiable risk factor in sickle cell disease: a review of the current literature and areas for future research, Int J Environ Res Public Health, 13, 1131, 10.3390/ijerph13111131 · DOI
- Cohen, 2013, Environmental tobacco smoke and airway obstruction in children with sickle cell anemia, Chest, 144, 1323, 10.1378/chest.12-1569 · DOI
- Pacht, 1988, Decreased ceruloplasmin ferroxidase activity in cigarette smokers, J Lab Clin Med, 111, 661
- Ingebrigtsen, 2010, Genetic influences on chronic obstructive pulmonary disease – a twin study, Respir Med, 104, 1890, 10.1016/j.rmed.2010.05.004 · DOI
- Lee, 2015, IREB2 and GALC are associated with pulmonary artery enlargement in chronic obstructive pulmonary disease, Am J Respir Cell Mol Biol, 52, 365, 10.1165/rcmb.2014-0210OC · DOI
- Kim, 2012, Association of IREB2 and CHRNA3 polymorphisms with airflow obstruction in severe alpha-1 antitrypsin deficiency, Respir Res, 13, 16, 10.1186/1465-9921-13-16 · DOI
- Siedlinski, 2013, Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility, Hum Genet, 132, 431, 10.1007/s00439-012-1262-3 · DOI
- Zhou, 2012, Association of IREB2 and CHRNA3/5 polymorphisms with COPD and COPD-related phenotypes in a Chinese Han population, J Hum Genet, 57, 738, 10.1038/jhg.2012.104 · DOI
- Ziółkowska-Suchanek, 2015, Susceptibility loci in lung cancer and COPD: association of IREB2 and FAM13A with pulmonary diseases, Sci Rep, 5, 13502, 10.1038/srep13502 · DOI
- Liu, 2016, Focused analysis of exome sequencing data for rare germline mutations in familial and sporadic lung cancer, J Thorac Oncol, 11, 52, 10.1016/j.jtho.2015.09.015 · DOI
- Pillai, 2009, A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci, PLoS Genet, 5, e1000421, 10.1371/journal.pgen.1000421 · DOI · Paper page
- He, 2009, Associations of IL6 polymorphisms with lung function decline and COPD, Thorax, 64, 698, 10.1136/thx.2008.111278 · DOI
- Ghio, 2013, Deficiency of α-1-antitrypsin influences systemic iron homeostasis, Int J Chron Obstruct Pulmon Dis, 8, 45, 10.2147/COPD.S37897 · DOI
- Fischer, 2009, Neutrophil elastase increases airway epithelial nonheme iron levels, Clin Transl Sci, 2, 333, 10.1111/j.1752-8062.2009.00151.x · DOI
- Lam, 2010, HFE mutations in alpha-1-antitrypsin deficiency: an examination of cirrhotic explants, Mod Pathol, 23, 637, 10.1038/modpathol.2010.42 · DOI
- Linet, 1999, Primary liver cancer, other malignancies, and mortality risks following porphyria: a cohort study in Denmark and Sweden, Am J Epidemiol, 149, 1010, 10.1093/oxfordjournals.aje.a009745 · doi:10.1093/oxfordjournals.aje.a009745
- Bala, 2010, Chronic obstructive pulmonary disease in iron-steel and ferrochrome industry workers, Cent Eur J Public Health, 18, 93, 10.21101/cejph.a3548 · DOI
- Hedlund, 2006, Persistence of respiratory symptoms in ex-underground iron ore miners, Occup Med (Lond), 56, 380, 10.1093/occmed/kql035 · DOI
- Adelroth, 2006, Airway inflammation in iron ore miners exposed to dust and diesel exhaust, Eur Respir J, 27, 714, 10.1183/09031936.06.00034705 · doi:10.1183/09031936.06.00034705
- Hedlund, 2004, Respiratory symptoms and obstructive lung diseases in iron ore miners: report from the obstructive lung disease in northern Sweden studies, Eur J Epidemiol, 19, 953, 10.1007/s10654-004-5194-7 · DOI
- Hirayama, 2010, Dietary intake of six minerals in relation to the risk of chronic obstructive pulmonary disease, Asia Pac J Clin Nutr, 19, 572
- Dickens, 2011, COPD association and repeatability of blood biomarkers in the ECLIPSE cohort, Respir Res, 12, 146, 10.1186/1465-9921-12-146 · DOI · Paper page
- Portillo, 2013, Anaemia in chronic obstructive pulmonary disease: does it really matter?, Int J Clin Pract, 67, 558, 10.1111/ijcp.12125 · DOI
- Tandara, 2015, Systemic inflammation up-regulates serum hepcidin in exacerbations and stabile chronic obstructive pulmonary disease, Clin Biochem, 48, 1252, 10.1016/j.clinbiochem.2015.07.010 · DOI
- Silverberg, 2014, Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron, BMC Pulm Med, 14, 24, 10.1186/1471-2466-14-24 · DOI
- Plesner, 2017, Iron deficiency in COPD associates with increased pulmonary artery pressure estimated by echocardiography, Heart Lung Circ, 26, 101, 10.1016/j.hlc.2016.04.020 · DOI
- Frise, 2016, Clinical iron deficiency disturbs normal human responses to hypoxia, J Clin Invest, 126, 2139, 10.1172/JCI85715 · DOI · Paper page
- Boutou, 2015, Non-anaemic iron deficiency in COPD: a potential therapeutic target?, Respirology, 20, 1004, 10.1111/resp.12616 · DOI
- Barberan-Garcia, 2015, Non-anaemic iron deficiency impairs response to pulmonary rehabilitation in COPD, Respirology, 20, 1089, 10.1111/resp.12591 · DOI
- Chen, 2012, Cellular and mitochondrial iron homeostasis in vertebrates, Biochim Biophys Acta, 1823, 1459, 10.1016/j.bbamcr.2012.01.003 · DOI · Paper page
- Chung, 2008, Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction, Eur Respir J, 31, 1334, 10.1183/09031936.00018908 · DOI · Paper page
- Wiegman, 2015, Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease, J Allergy Clin Immunol, 136, 769, 10.1016/j.jaci.2015.01.046 · DOI · Paper page
- Rahman, 2006, Oxidative stress and redox regulation of lung inflammation in COPD, Eur Respir J, 28, 219, 10.1183/09031936.06.00053805 · DOI · Paper page
- Kamp, 1998, Cigarette smoke augments asbestos-induced alveolar epithelial cell injury: role of free radicals, Free Radic Biol Med, 25, 728, 10.1016/S0891-5849(98)00158-0 · DOI · Paper page
- Wesselius, 1999, Iron uptake promotes hyperoxic injury to alveolar macrophages, Am J Respir Crit Care Med, 159, 100, 10.1164/ajrccm.159.1.9801033 · DOI
- Dai, 2002, Iron loading makes a nonfibrogenic model air pollutant particle fibrogenic in rat tracheal explants, Am J Respir Cell Mol Biol, 26, 685, 10.1165/ajrcmb.26.6.4651 · DOI · Paper page
- Smith, 2010, Inflammatory response of lung macrophages and epithelial cells to tobacco smoke: a literature review of ex vivo investigations, Immunol Res, 46, 94, 10.1007/s12026-009-8133-6 · DOI
- Gally, 2013, Cigarette smoke decreases airway epithelial FABP5 expression and promotes Pseudomonas aeruginosa infection, PLoS One, 8, e51784, 10.1371/journal.pone.0051784 · DOI
- Brunk, 2001, Lysosomal involvement in apoptosis, Redox Rep, 6, 91, 10.1179/135100001101536094 · DOI · Paper page
- Yatmark, 2015, Effects of iron chelators on pulmonary iron overload and oxidative stress in β-thalassemic mice, Pharmacology, 96, 192, 10.1159/000438994 · DOI
- Filosa, 2013, Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major, Blood Cells Mol Dis, 51, 85, 10.1016/j.bcmd.2013.04.002 · DOI
- Schönhofer, 1998, Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease, Crit Care Med, 26, 1824, 10.1097/00003246-199811000-00022 · DOI
- Schönhofer, 1998, Blood transfusion facilitating difficult weaning from the ventilator, Anaesthesia, 53, 181, 10.1046/j.1365-2044.1998.00275.x · DOI · Paper page
- John, 2005, Anemia and inflammation in COPD, Chest, 127, 825, 10.1378/chest.127.3.825 · DOI · Paper page
- Tassiopoulos, 2001, Erythropoietic response to hypoxaemia in diffuse idiopathic pulmonary fibrosis, as opposed to chronic obstructive pulmonary disease, Respir Med, 95, 471, 10.1053/rmed.2001.1070 · doi:10.1053/rmed.2001.1070
- Sala, 2010, Low erythropoietin plasma levels during exacerbations of COPD, Respiration, 80, 190, 10.1159/000264604 · DOI
- Smith, 2008, The increase in pulmonary arterial pressure caused by hypoxia depends on iron status, J Physiol, 586, 5999, 10.1113/jphysiol.2008.160960 · DOI · Paper page
- Schoos, 2013, Echocardiographic predictors of exercise capacity and mortality in chronic obstructive pulmonary disease, BMC Cardiovasc Disord, 13, 84, 10.1186/1471-2261-13-84 · DOI
- Steinbicker, 2013, Out of balance—systemic iron homeostasis in iron-related disorders, Nutrients, 5, 3034, 10.3390/nu5083034 · DOI · Paper page
- Van Buren, 2012, Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD, Int Urol Nephrol, 44, 499, 10.1007/s11255-011-0028-5 · DOI
- DePalma, 2013, Reduction of iron stores and clinical outcomes in peripheral arterial disease: outcome comparisons in smokers and non-smokers, Vascular, 21, 233, 10.1177/1708538113478776 · DOI
- Martinez, 1997, Iron stores and coagulation parameters in patients with hypoxemic polycythemia secondary to chronic obstructive pulmonary disease: the effect of phlebotomies, Sao Paulo Med J, 115, 1395, 10.1590/S1516-31801997000200005 · DOI
- Chetty, 1990, Exercise performance of polycythemic chronic obstructive pulmonary disease patients. Effect of phlebotomies, Chest, 98, 1073, 10.1378/chest.98.5.1073 · DOI
Cited by
Iron Homeostasis in the Lungs—A Balance between Health and Disease
Neves, J., Haider, T., Gassmann, M., & Muckenthaler, M. U. (2019) · Pharmaceuticals · doi:10.3390/ph12010005 · Cited by 94
Lee, J., Arisi, I., Puxeddu, E., Mramba, L. K., Amicosante, M., Swaisgood, C. M., Pallante, M., Brantly, M. L., Sköld, C. M., & Saltini, C. (2018) · PLOS ONE · doi:10.1371/journal.pone.0194803 · Cited by 69
Smoking-induced iron dysregulation in the lung
Zhang, W. Z., Butler, J. J., & Cloonan, S. M. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.07.024 · Cited by 62
“Production of hepcidin by AMs has also been described, indicating a specific local role in the lung for this hormone [2,52].”
InfluentialSelf-citationZhang, V., Nemeth, E., & Kim, A. (2019) · Pharmaceuticals · doi:10.3390/ph12010030 · Cited by 57
“As in smokers, levels of iron and iron-binding proteins are increased in the lung tissue, BAL fluid, and alveolar macrophages of COPD patients, and iron levels are correlated with disease severity and with worsening lung function [64].”
Background
Metadata
- Authors
- Cloonan, S. M., Mumby, S., Adcock, I. M., Choi, A. M. K., Chung, K. F., & Quinlan, G. J.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-11-01
- Volume
- 196
- Issue
- 9
- Pages
- 1103-1112
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2605628036
- Cited by
- 106
- References
- 24
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.